Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 14h ago.
Showing the 15 most recent target moves.
| Outperform |
| $55 $64 |
| Aug 12 |
| NTAPNetApp, Inc. | Wedbush | Maintained | Neutral | $150 $170 | 6d ago |
| ARGXargenx SE | Wedbush | Maintained | Outperform | $1,050 $1,150 | Aug 18 |
| NTLAIntellia Therapeutics, Inc. | Wedbush | Maintained | Neutral | $12 $13 | 1d ago |
| DUOLDuolingo, Inc. | Wedbush | Maintained | Neutral | $139 $150 | Aug 20 |
| DASHDoorDash, Inc. | Wedbush | Maintained | Neutral | $205 $220 | Aug 20 |
| VRSNVeriSign, Inc. | Wedbush | Maintained | Outperform | $324 $341 | Sep 1 |
| NVDANVIDIA Corporation | Wedbush | Maintained | Outperform | $330 $345 | Aug 27 |
| CBRSCerebras Systems Inc. | Wedbush | Maintained | Outperform | $280 $290 | Aug 13 |
| EBAYeBay Inc. | Wedbush | Maintained | Outperform | $135 $137 | Aug 20 |
| SYRESpyre Therapeutics, Inc. | Wedbush | Maintained | Outperform | $130 $123 | Aug 26 |
| VERAVera Therapeutics, Inc. | Wedbush | Maintained | Neutral | $43 $34 | Aug 11 |
| SIONSionna Therapeutics, Inc. | Wedbush | Downgraded from Outperform | Neutral | $53 $5 | Aug 11 |